CONFERA

Welcome to the Brand page for “CONFERA”, which is offered here for Diagnostic kits comprised primarily of diagnostic reagents for medical use in the field of cancer; diagnostic test kits for medical use comprised primarily of reagents for liquid biopsy; medical diagnostic reagents for testing of body fluids; kits consisting primarily of medical diagnostic reagents for testing of body fluids;the english translation of confera in the mark is gives.;medical diagnostic monitoring, testing and reporting services and cellular medical diagnostic testing services in the field of cancer, all for medical diagnostic or treatment purposes; providing medical information in the form of information reports and clinical diagnostics reports in the field of cancer; providing laboratory testing and computational analysis, for human and veterinary testing, cellular analysis, and related reporting services in the field of cancer, all for medical diagnostic or treatment purposes;scientific research and development in the fields of cancer research, biology, laboratory testing for scientific and medical research purposes, biotechnology, biochemistry, and medicine; medical and scientific research and product development services for others in the fields of cancer research, biology, laboratory testing for scientific and medical research purposes, biotechnology, biochemistry, and medicine; medical and scientific research for the detection of cancer; providing laboratory research services in the field of cancer; structural and functional analysis of cancer cells for medical and scientific research purposes; providing information on the subject of scientific research in the fields of cancer research, biology, laboratory testing, biotechnology, biochemistry, and medicine; providing laboratory testing and computational analysis, for human and veterinary testing, genetic analysis, and related reporting services, all for scientific purposes;.

Its status is currently believed to be active. Its class is unavailable. “CONFERA” is believed to be currently owned by “LEXENT BIO, INC.”